{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T16:38:26Z","timestamp":1791650306557,"version":"4.3.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T00:00:00Z","timestamp":1558051200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T00:00:00Z","timestamp":1558051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s10637-019-00781-9","type":"journal-article","created":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T03:05:28Z","timestamp":1558062328000},"page":"329-339","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Cardamonin, a natural chalcone, reduces 5-fluorouracil resistance of gastric cancer cells through targeting Wnt\/\u03b2-catenin signal pathway"],"prefix":"10.1007","volume":"38","author":[{"given":"Gaochao","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaoyu","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4612-719X","authenticated-orcid":false,"given":"Xianli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,17]]},"reference":[{"key":"781_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:1\u201331. https:\/\/doi.org\/10.3322\/caac.21492","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"781_CR2","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359\u2013E386. https:\/\/doi.org\/10.1002\/ijc.29210","journal-title":"Int J Cancer"},{"issue":"5","key":"781_CR3","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1158\/1055-9965.EPI-13-1057","volume":"23","author":"P Karimi","year":"2014","unstructured":"Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F (2014) Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomark Prev 23(5):700\u2013713. https:\/\/doi.org\/10.1158\/1055-9965.EPI-13-1057","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"9","key":"781_CR4","doi-asserted-by":"publisher","first-page":"673","DOI":"10.4251\/wjgo.v8.i9.673","volume":"8","author":"W-J Shi","year":"2016","unstructured":"Shi W-J, Gao J-B (2016) Molecular mechanisms of chemoresistance in gastric cancer. World J Gastrointest Oncol 8(9):673\u2013681. https:\/\/doi.org\/10.4251\/wjgo.v8.i9.673","journal-title":"World J Gastrointest Oncol"},{"key":"781_CR5","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1177\/147323001003800104","volume":"38","author":"H-W Xu","year":"2010","unstructured":"Xu H-W, Xu L, Hao J-H, Qin CY, Liu H (2010) Expression of P-glycoprotein and multidrug resistance-associated protein is associated with multidrug resistance in gastric cancer. J Int Med Res 38:34\u201342. https:\/\/doi.org\/10.1177\/147323001003800104","journal-title":"J Int Med Res"},{"issue":"5","key":"781_CR6","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrc1074","volume":"3","author":"DB Longley","year":"2003","unstructured":"Longley DB, Harkin DP, Johnston PG (2003) 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 3(5):330\u2013338. https:\/\/doi.org\/10.1038\/nrc1074","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"781_CR7","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/nrc3599","volume":"13","author":"C Holohan","year":"2013","unstructured":"Holohan C, van Schaeybroeck S, Longley DB, Johnston PG (2013) Cancer drug resistance: an evolving paradigm. Nat Rev Cancer 13(10):714\u2013726. https:\/\/doi.org\/10.1038\/nrc3599","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"781_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0014-2999(00)00743-3","volume":"408","author":"F Ushigome","year":"2000","unstructured":"Ushigome F, Takanaga H, Matsuo H, Yanai S, Tsukimori K, Nakano H, Uchiumi T, Nakamura T, Kuwano M, Ohtani H, Sawada Y (2000) Human placental transport of vinblastine, vincristine, digoxin and progesterone: contribution of P-glycoprotein. Eur J Pharmacol 408(1):1\u201310","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"781_CR9","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0014-2999(00)00047-9","volume":"391","author":"C Marbeuf-Gueye","year":"2000","unstructured":"Marbeuf-Gueye C, Salerno M, Quidu P, Garnier-Suillerot A (2000) Inhibition of the P-glycoprotein- and multidrug resistance protein-mediated efflux of anthracyclines and calceinacetoxymethyl ester by PAK-104P. Eur J Pharmacol 391(3):207\u2013216. https:\/\/doi.org\/10.1016\/S0014-2999(00)00047-9","journal-title":"Eur J Pharmacol"},{"issue":"5\u20136","key":"781_CR10","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/S0006-2952(02)01156-5","volume":"64","author":"S Labialle","year":"2002","unstructured":"Labialle S, Gayet L, Marthinet E, Rigal D, Baggetto LG (2002) Transcriptional regulators of the human multidrug resistance 1 gene: recent views. Biochem Pharmacol 64(5\u20136):943\u2013948","journal-title":"Biochem Pharmacol"},{"issue":"7","key":"781_CR11","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1158\/1078-0432.CCR-11-1590","volume":"18","author":"KG Chen","year":"2012","unstructured":"Chen KG, Sikic BI (2012) Molecular pathways: regulation and therapeutic implications of multidrug resistance. Clin Cancer Res 18(7):1863\u20131869. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-1590","journal-title":"Clin Cancer Res"},{"issue":"3","key":"781_CR12","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.3892\/or.2013.2222","volume":"29","author":"B Tang","year":"2013","unstructured":"Tang B, Zhang Y, Liang R et al (2013) RNAi-mediated EZH2 depletion decreases MDR1 expression and sensitizes multidrug-resistant hepatocellular carcinoma cells to chemotherapy. Oncol Rep 29(3):1037\u20131042. https:\/\/doi.org\/10.3892\/or.2013.2222","journal-title":"Oncol Rep"},{"issue":"2","key":"781_CR13","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/IGC.0b013e31820aaadb","volume":"21","author":"C Peng","year":"2011","unstructured":"Peng C, Zhang X, Yu H, Wu D, Zheng J (2011) Wnt5a as a predictor in poor clinical outcome of patients and a mediator in chemoresistance of ovarian cancer. Int J Gynecol Cancer 21(2):280\u2013288. https:\/\/doi.org\/10.1097\/IGC.0b013e31820aaadb","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"781_CR14","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1007\/s13277-012-0478-0","volume":"33","author":"SD Vangipuram","year":"2012","unstructured":"Vangipuram SD, Buck SA, Lyman WD (2012) Wnt pathway activity confers chemoresistance to cancer stem-like cells in a neuroblastoma cell line. Tumour Biol 33(6):2173\u20132183. https:\/\/doi.org\/10.1007\/s13277-012-0478-0","journal-title":"Tumour Biol"},{"issue":"10","key":"781_CR15","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1038\/sj.bjc.6605064","volume":"100","author":"T Noda","year":"2009","unstructured":"Noda T, Nagano H, Takemasa I, Yoshioka S, Murakami M, Wada H, Kobayashi S, Marubashi S, Takeda Y, Dono K, Umeshita K, Matsuura N, Matsubara K, Doki Y, Mori M, Monden M (2009) Activation of Wnt\/beta-catenin signalling pathway induces chemoresistance to interferon-alpha\/5-fluorouracil combination therapy for hepatocellular carcinoma. Br J Cancer 100(10):1647\u20131658. https:\/\/doi.org\/10.1038\/sj.bjc.6605064","journal-title":"Br J Cancer"},{"issue":"2","key":"781_CR16","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.bbrc.2012.07.127","volume":"425","author":"N Xu","year":"2012","unstructured":"Xu N, Shen C, Luo Y, Xia L, Xue F, Xia Q, Zhang J (2012) Upregulated miR-130a increases drug resistance by regulating RUNX3 and Wnt signaling in cisplatin-treated HCC cell. Biochem Biophys Res Commun 425(2):468\u2013472. https:\/\/doi.org\/10.1016\/j.bbrc.2012.07.127","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"781_CR17","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.bbrc.2012.12.118","volume":"431","author":"Y Ma","year":"2013","unstructured":"Ma Y, Ren Y, Han EQ, Li H, Chen D, Jacobs JJ, Gitelis S, O\u2019Keefe RJ, Konttinen YT, Yin G, Li TF (2013) Inhibition of the Wnt-\u03b2-catenin and Notch signaling pathways sensitizes osteosarcoma cells to chemotherapy. Biochem Biophys Res Commun 431(2):274\u2013279. https:\/\/doi.org\/10.1016\/j.bbrc.2012.12.118","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"781_CR18","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1111\/cas.12223","volume":"104","author":"DY Shen","year":"2013","unstructured":"Shen DY, Zhang W, Zeng X, Liu CQ (2013) Inhibition of Wnt\/beta-catenin signaling downregulates P-glycoprotein and reverses multi-drug resistance of cholangiocarcinoma. Cancer Sci 104(10):1303\u20131308. https:\/\/doi.org\/10.1111\/cas.12223","journal-title":"Cancer Sci"},{"issue":"1\u20132","key":"781_CR19","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s11010-013-1695-6","volume":"381","author":"Y Wei","year":"2013","unstructured":"Wei Y, Shen N, Wang Z, Yang G, Yi B, Yang N, Qiu Y, Lu J (2013) Sorafenib sensitizes hepatocellular carcinoma cell to cisplatin via suppression of Wnt\/\u03b2-catenin signaling. Mol Cell Biochem 381(1\u20132):139\u2013144. https:\/\/doi.org\/10.1007\/s11010-013-1695-6","journal-title":"Mol Cell Biochem"},{"issue":"9","key":"781_CR20","doi-asserted-by":"publisher","first-page":"703","DOI":"10.7150\/jca.7235","volume":"4","author":"A Ouhtit","year":"2013","unstructured":"Ouhtit A, Gaur RL, Abdraboh M, Ireland SK, Rao PN, Raj SG, al-Riyami H, Shanmuganathan S, Gupta I, Murthy SN, Hollenbach A, Raj MHG (2013) Simultaneous inhibition of cell-cycle, proliferation, survival, metastatic pathways and induction of apoptosis in breast cancer cells by a phytochemical super-cocktail: genes that underpin its mode of action. J Cancer 4(9):703\u2013715. https:\/\/doi.org\/10.7150\/jca.7235","journal-title":"J Cancer"},{"issue":"6","key":"781_CR21","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1089\/jmf.2013.0061","volume":"17","author":"LM Gon\u00e7alves","year":"2014","unstructured":"Gon\u00e7alves LM, Valente IM, Rodrigues JA (2014) An overview on cardamonin. J Med Food 17(6):633\u2013640. https:\/\/doi.org\/10.1089\/jmf.2013.0061","journal-title":"J Med Food"},{"issue":"47","key":"781_CR22","doi-asserted-by":"publisher","first-page":"82842","DOI":"10.18632\/oncotarget.20666","volume":"8","author":"H Tang","year":"2017","unstructured":"Tang H, Zeng L, Wang J et al (2017) Reversal of 5-fluorouracil resistance by EGCG is mediate by inactivation of TFAP2A\/VEGF signaling pathway and down-regulation of MDR-1 and P-gp expression in gastric cancer. Oncotarget 8(47):82842\u201382853. https:\/\/doi.org\/10.18632\/oncotarget.20666","journal-title":"Oncotarget"},{"issue":"12","key":"781_CR23","first-page":"3681","volume":"50","author":"DS Heo","year":"1990","unstructured":"Heo DS, Park JG, Hata K, Day R, Herberman RB, Whiteside TL (1990) Evaluation of tetrazolium-based semiautomatic colorimetric assay for measurement of human antitumor cytotoxicity. Cancer Res 50(12):3681\u20133690","journal-title":"Cancer Res"},{"issue":"1","key":"781_CR24","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/ijc.11528","volume":"108","author":"K Shiozawa","year":"2004","unstructured":"Shiozawa K, Oka M, Soda H, Yoshikawa M, Ikegami Y, Tsurutani J, Nakatomi K, Nakamura Y, Doi S, Kitazaki T, Mizuta Y, Murase K, Yoshida H, Ross DD, Kohno S (2004) Reversal of breast cancer resistance protein (BCRP\/ABCG2)-mediated drug resistance by novobiocin, a coumermycin antibiotic. Int J Cancer 108(1):146\u2013151. https:\/\/doi.org\/10.1002\/ijc.11528","journal-title":"Int J Cancer"},{"issue":"13","key":"781_CR25","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.2174\/092986712800167392","volume":"19","author":"A Palmeira","year":"2012","unstructured":"Palmeira A, Sousa E, Vasconcelos MH et al (2012) Three decades of P-gp inhibitors: skimming through several generations and scaffolds. Curr Med Chem 19(13):1946\u20132025","journal-title":"Curr Med Chem"},{"issue":"12","key":"781_CR26","doi-asserted-by":"publisher","first-page":"5421","DOI":"10.1002\/jps.21372","volume":"97","author":"N Shaik","year":"2008","unstructured":"Shaik N, Pan G, Elmquist WF (2008) Interactions of pluronic block copolymers on P-gp efflux activity: experience with HIV-1 protease inhibitors. J Pharm Sci 97(12):5421\u20135433. https:\/\/doi.org\/10.1002\/jps.21372","journal-title":"J Pharm Sci"},{"issue":"1","key":"781_CR27","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.canlet.2005.10.050","volume":"241","author":"G Wang","year":"2006","unstructured":"Wang G, Chen H, Huang M, Wang N, Zhang J, Zhang Y, Bai G, Fong WF, Yang M, Yao X (2006) Methyl protodioscin induces G2\/M cell cycle arrest and apoptosis in HepG2 liver cancer cells. Cancer Lett 241(1):102\u2013109. https:\/\/doi.org\/10.1016\/j.canlet.2005.10.050","journal-title":"Cancer Lett"},{"issue":"2","key":"781_CR28","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.gene.2014.10.024","volume":"555","author":"S-X Gu","year":"2015","unstructured":"Gu S-X, Li X, Hamilton JL, Chee A, Kc R, Chen D, An HS, Kim JS, Oh CD, Ma YZ, van Wijnen AJ, Im HJ (2015) MicroRNA-146a reduces IL-1 dependent inflammatory responses in the intervertebral disc. Gene 555(2):80\u201387. https:\/\/doi.org\/10.1016\/j.gene.2014.10.024","journal-title":"Gene"},{"issue":"24","key":"781_CR29","doi-asserted-by":"publisher","first-page":"10351","DOI":"10.1158\/0008-5472.CAN-10-0740","volume":"70","author":"G Qing","year":"2010","unstructured":"Qing G, Skuli N, Mayes PA, Pawel B, Martinez D, Maris JM, Simon MC (2010) Combinatorial regulation of neuroblastoma tumor progression by N-Myc and hypoxia inducible factor HIF-1alpha. Cancer Res 70(24):10351\u201310361. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-0740","journal-title":"Cancer Res"},{"issue":"5","key":"781_CR30","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.3892\/etm.2015.2762","volume":"10","author":"Q Li","year":"2015","unstructured":"Li Q, Wang X, Shen A et al (2015) Hedyotis diffusa Willd overcomes 5-fluorouracil resistance in human colorectal cancer HCT-8\/5-FU cells by downregulating the expression of P-glycoprotein and ATP-binding casette subfamily G member 2. Exp Ther Med 10(5):1845\u20131850. https:\/\/doi.org\/10.3892\/etm.2015.2762","journal-title":"Exp Ther Med"},{"issue":"17","key":"781_CR31","first-page":"4761","volume":"60","author":"T Yamada","year":"2000","unstructured":"Yamada T, Takaoka AS, Naishiro Y et al (2000) Transactivation of the multidrug resistance 1 gene by T-cell factor 4\/beta-catenin complex in early colorectal carcinogenesis. Cancer Res 60(17):4761\u20134766","journal-title":"Cancer Res"},{"issue":"1","key":"781_CR32","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nrc706","volume":"2","author":"MM Gottesman","year":"2002","unstructured":"Gottesman MM, Fojo T, Bates SE (2002) Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2(1):48\u201358. https:\/\/doi.org\/10.1038\/nrc706","journal-title":"Nat Rev Cancer"},{"key":"781_CR33","doi-asserted-by":"publisher","first-page":"68623","DOI":"10.18632\/oncotarget.11864","volume":"7","author":"L-l Xia","year":"2016","unstructured":"Xia L-l, Tang Y-b, Song F-f et al (2016) DCTPP1 attenuates the sensitivity of human gastric cancer cells to 5-fluorouracil by up-regulating MDR1 expression epigenetically. Oncotarget 7:68623\u201368637. https:\/\/doi.org\/10.18632\/oncotarget.11864","journal-title":"Oncotarget"},{"issue":"10","key":"781_CR34","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1586\/14737140.7.10.1369","volume":"7","author":"D Zhang","year":"2007","unstructured":"Zhang D, Fan D (2007) Multidrug resistance in gastric cancer: recent research advances and ongoing therapeutic challenges. Expert Rev Anticancer Ther 7(10):1369\u20131378. https:\/\/doi.org\/10.1586\/14737140.7.10.1369","journal-title":"Expert Rev Anticancer Ther"},{"issue":"1","key":"781_CR35","first-page":"321","volume":"5","author":"L-H Yan","year":"2015","unstructured":"Yan L-H, Wei W-Y, Cao W-L, Zhang XS, Xie YB, Xiao Q (2015) Overexpression of CDX2 in gastric cancer cells promotes the development of multidrug resistance. Am J Cancer Res 5(1):321\u2013332","journal-title":"Am J Cancer Res"},{"issue":"2","key":"781_CR36","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.gene.2015.08.052","volume":"574","author":"D Liu","year":"2015","unstructured":"Liu D, Zhou H, Wu J, Liu W, Li Y, Shi G, Yue X, Sun X, Zhao Y, Hu X, Wang T, Zhang X (2015) Infection by Cx43 adenovirus increased chemotherapy sensitivity in human gastric cancer BGC-823 cells: not involving in induction of cell apoptosis. Gene 574(2):217\u2013224. https:\/\/doi.org\/10.1016\/j.gene.2015.08.052","journal-title":"Gene"},{"issue":"7","key":"781_CR37","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s10495-017-1379-x","volume":"22","author":"W Lian","year":"2017","unstructured":"Lian W, Zhang L, Yang L, Chen W (2017) AP-2\u03b1 reverses vincristine-induced multidrug resistance of SGC7901 gastric cancer cells by inhibiting the Notch pathway. Apoptosis 22(7):933\u2013941. https:\/\/doi.org\/10.1007\/s10495-017-1379-x","journal-title":"Apoptosis"},{"issue":"2","key":"781_CR38","doi-asserted-by":"publisher","first-page":"592","DOI":"10.3892\/or.2012.1823","volume":"28","author":"L Yang","year":"2012","unstructured":"Yang L, Li N, Wang H et al (2012) Altered microRNA expression in cisplatin-resistant ovarian cancer cells and upregulation of miR-130a associated with MDR1\/P-glycoprotein-mediated drug resistance. Oncol Rep 28(2):592\u2013600. https:\/\/doi.org\/10.3892\/or.2012.1823","journal-title":"Oncol Rep"},{"issue":"1","key":"781_CR39","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.gendis.2015.12.004","volume":"3","author":"MK Mohammed","year":"2016","unstructured":"Mohammed MK, Shao C, Wang J, Wei Q, Wang X, Collier Z, Tang S, Liu H, Zhang F, Huang J, Guo D, Lu M, Liu F, Liu J, Ma C, Shi LL, Athiviraham A, He TC, Lee MJ (2016) Wnt\/\u03b2-catenin signaling plays an ever-expanding role in stem cell self-renewal, tumorigenesis and cancer chemoresistance. Genes Dis 3(1):11\u201340. https:\/\/doi.org\/10.1016\/j.gendis.2015.12.004","journal-title":"Genes Dis"},{"issue":"42","key":"781_CR40","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/1471-2407-12-303","volume":"12","author":"S Corr\u00eaa","year":"2012","unstructured":"Corr\u00eaa S, Binato R, Du Rocher B et al (2012) Wnt\/\u03b2-catenin pathway regulates ABCB1 transcription in chronic myeloid leukemia. BMC Cancer 12(42):303\u2013309. https:\/\/doi.org\/10.1186\/1471-2407-12-303","journal-title":"BMC Cancer"},{"issue":"3","key":"781_CR41","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2174\/1574888X11666161028143224","volume":"12","author":"G Shukla","year":"2017","unstructured":"Shukla G, Khera HK, Srivastava AK, Khare P, Patidar R, Saxena R (2017) Therapeutic potential, challenges and future perspective of cancer stem cells in therapeutic potential, challenges and future perspective of cancer stem cells in translational oncology: a critical review. Curr Stem Cell Res Ther 12(3):207\u2013224. https:\/\/doi.org\/10.2174\/1574888X11666161028143224","journal-title":"Curr Stem Cell Res Ther"},{"issue":"6859","key":"781_CR42","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/35102167","volume":"414","author":"T Reya","year":"2001","unstructured":"Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Stem cells, cancer, and cancer stem cells. Nature 414(6859):105\u2013111. https:\/\/doi.org\/10.1038\/35102167","journal-title":"Nature"},{"issue":"1","key":"781_CR43","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1096\/fj.12-218222","volume":"27","author":"V Tirino","year":"2013","unstructured":"Tirino V, Desiderio V, Paino F, de Rosa A, Papaccio F, la Noce M, Laino L, de Francesco F, Papaccio G (2013) Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization. FASEB J 27(1):13\u201324. https:\/\/doi.org\/10.1096\/fj.12-218222","journal-title":"FASEB J"},{"key":"781_CR44","first-page":"5821","volume":"63","author":"SK Singh","year":"2003","unstructured":"Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, Dirks PB (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res 63:5821\u20135828","journal-title":"Cancer Res"},{"issue":"18","key":"781_CR45","doi-asserted-by":"publisher","first-page":"8671","DOI":"10.1158\/0008-5472.CAN-07-1486","volume":"67","author":"JC Liu","year":"2007","unstructured":"Liu JC, Deng T, Lehal RS, Kim J, Zacksenhaus E (2007) Identification of tumorsphere- and tumor-initiating cells in HER2\/Neu-induced mammary tumors. Cancer Res 67(18):8671\u20138681. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-1486","journal-title":"Cancer Res"},{"key":"781_CR46","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.semcancer.2014.07.001","volume":"31","author":"E Vlashi","year":"2015","unstructured":"Vlashi E, Pajonk F (2015) Cancer stem cells, cancer cell plasticity and radiation therapy. Semin Cancer Biol 31:28\u201335. https:\/\/doi.org\/10.1016\/j.semcancer.2014.07.001","journal-title":"Semin Cancer Biol"},{"key":"781_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2011\/941876","volume":"2011","author":"R Morrison","year":"2011","unstructured":"Morrison R, Schleicher SM, Sun Y, Niermann KJ, Kim S, Spratt DE, Chung CH, Lu B (2011) Targeting the mechanisms of resistance to chemotherapy and radiotherapy with the cancer stem cell hypothesis. J Oncol 2011:1\u201313. https:\/\/doi.org\/10.1155\/2011\/941876","journal-title":"J Oncol"},{"key":"781_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/cddis.2013.515","volume":"5","author":"J Mao","year":"2014","unstructured":"Mao J, Fan S, Ma W, Fan P, Wang B, Zhang J, Wang H, Tang B, Zhang Q, Yu X, Wang L, Song B, Li L (2014) Roles of Wnt\/\u03b2-catenin signaling in the gastric cancer stem cells proliferation and salinomycin treatment. Cell Death Dis 5:1\u20139. https:\/\/doi.org\/10.1038\/cddis.2013.515","journal-title":"Cell Death Dis"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-019-00781-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-019-00781-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-019-00781-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T13:43:50Z","timestamp":1678542230000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-019-00781-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,17]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["781"],"URL":"https:\/\/doi.org\/10.1007\/s10637-019-00781-9","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,17]]},"assertion":[{"value":"25 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare to have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed. The manuscript does not contain clinical studies or patient data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}